Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Clinical trial NCT01363817 · COMPLETED
Trial details
- NCT number
- NCT01363817
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-28
- Primary completion
- 2018-02-07
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.